The global neuromonitoring devices market was valued at $5,593.1 million in 2021 and is projected to reach $10,276 million by 2030, growing at a CAGR of 7.24% from 2022 to 2030.

    

Rising demand for non-invasive and minimally invasive medical devices is expected to drive the global nuromonitoring devices market. Because it includes intervention with sensitive brain tissue, intrusive tracking is a complex, distressing, and dangerous procedure. As a result, both patients and doctors prefer the use of non-invasive or non-invasive nuromonitoring devices. Because of their advantages, non-invasive ICP monitoring systems, computed tomography devices, tympanic displacement procedures, nervous system sheath diameter, chest x ray, and fundoscopy have seen a rapid upsurge, compelling market participants to grow and commercialize such products. All such factors are expected to drive the neuromonitoring devices market during the forecast period.

The market for neuromonitoring devices is likely to face some major hindrance due to high cost of the devices. Neuromonitoring devices are highly expensive due to the use of many costly equipment such as advanced sensors, electrodes, and wirings used for their construction. Also, less availability of skilled personnel to operate such devices is further anticipated to impede the market growth.

To meet the rising demand for advanced neuromonitoring devices, key market players are constantly innovating their portfolio of neuromonitoring devices. For this reason, companies have begun to invest heavily in advancing their research and development activities and developing new and advanced product lines.

The global neuromonitoring devices market is segmented on the basis of product and region. By product, the market is classified into intracranial pressure monitoring, cerebral oximeter, near infrared spectroscopy, speckle imaging, doppler ultrasound, EEG, fetal/neonatal neuromonitoring devices, micro ultrasound, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.

By Product

Intracranial Pressure Monitoring

Cerebral Oximeter

Near Infrared Spectroscopy

Speckle Imaging

Doppler Ultrasound

EEG

Fetal/Neonatal Neuromonitoring devices

Micro Ultrasound

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

GE Healthcare

Koninklijke Philips N.V.

Medtronic Plc

Nihon Kohden Corporation

Natus Medical Incorporated

Nuvasive, Inc.

Advanced Brain Monitoring, Inc.

Intranerve Neuroscience Holdings, LLC

Specialtycare

RIMED Ltd.

By Product

● Intracranial Pressure Monitoring

● Cerebral Oximeter

● Near Infrared Spectroscopy

● Speckle Imaging

● Doppler Ultrasound

● EEG

● Fetal/Neonatal Neuro-Monitoring Devices

● Micro Ultrasound

● Others

By Region

● North America

○ U.S.

○ Canada

○ Mexico

● Europe

○ Germany

○ United Kingdom

○ France

○ Spain

○ Italy

○ Rest of Europe

● Asia-Pacific

○ China

○ Japan

○ India

○ South Korea

○ Australia

○ Rest Of Asia Pacific

● LAMEA

○ Brazil

○ Saudi Arabia

○ UAE

○ South Africa

○ Rest of LAMEA

● Key Market Players

○ Koninklijke Philips N.V.

○ Nihon Kohden Corporation

○ Natus Medical Incorporated

○ Medtronic Plc

○ GE Healthcare

○ Nuvasive, Inc.

○ Advanced Brain Monitoring, Inc.

○ Intranerve Neuroscience Holdings, LLC

○ RIMED Ltd.

○ SpecialtyCar

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

3.7.Regulatory Guidelines

3.8.Value Chain Analysis

3.9.Market Share Analysis

3.10.Key Regulation Analysis

3.11.Patent Landscape

4.1 Overview

4.1.1 Market size and forecast

4.2 Intracranial Pressure Monitoring

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Cerebral Oximeter

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Near Infrared Spectroscopy

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Speckle Imaging

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

4.6 Doppler Ultrasound

4.6.1 Key market trends, growth factors and opportunities

4.6.2 Market size and forecast, by region

4.6.3 Market analysis by country

4.7 EEG

4.7.1 Key market trends, growth factors and opportunities

4.7.2 Market size and forecast, by region

4.7.3 Market analysis by country

4.8 Fetal/Neonatal Neuro-Monitoring Devices

4.8.1 Key market trends, growth factors and opportunities

4.8.2 Market size and forecast, by region

4.8.3 Market analysis by country

4.9 Micro Ultrasound

4.9.1 Key market trends, growth factors and opportunities

4.9.2 Market size and forecast, by region

4.9.3 Market analysis by country

5.0 Others

5.0.1 Key market trends, growth factors and opportunities

5.0.2 Market size and forecast, by region

5.0.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by Product

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by Product

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by Product

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by Product

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by Product

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Germany

5.3.3.1.1 Market size and forecast, by Product

5.3.3.2 United Kingdom

5.3.3.2.1 Market size and forecast, by Product

5.3.3.3 France

5.3.3.3.1 Market size and forecast, by Product

5.3.3.4 Spain

5.3.3.4.1 Market size and forecast, by Product

5.3.3.5 Italy

5.3.3.5.1 Market size and forecast, by Product

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by Product

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by Product

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 China

5.4.3.1.1 Market size and forecast, by Product

5.4.3.2 Japan

5.4.3.2.1 Market size and forecast, by Product

5.4.3.3 India

5.4.3.3.1 Market size and forecast, by Product

5.4.3.4 South Korea

5.4.3.4.1 Market size and forecast, by Product

5.4.3.5 Australia

5.4.3.5.1 Market size and forecast, by Product

5.4.3.6 Rest Of Asia Pacific

5.4.3.6.1 Market size and forecast, by Product

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by Product

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by Product

5.5.3.2 Saudi Arabia

5.5.3.2.1 Market size and forecast, by Product

5.5.3.3 UAE

5.5.3.3.1 Market size and forecast, by Product

5.5.3.4 South Africa

5.5.3.4.1 Market size and forecast, by Product

5.5.3.5 Rest of LAMEA

5.5.3.5.1 Market size and forecast, by Product

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 Koninklijke Philips N.V.

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 Nihon Kohden Corporation

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 Natus Medical Incorporated

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 Medtronic Plc

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 GE Healthcare

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 Nuvasive, Inc.

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 Advanced Brain Monitoring, Inc.

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and developments

7.8 Intranerve Neuroscience Holdings, LLC

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Product portfolio

7.8.5 Business performance

7.8.6 Key strategic moves and developments

7.9 RIMED Ltd.

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Product portfolio

7.9.5 Business performance

7.9.6 Key strategic moves and developments

7.10 SpecialtyCare

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Operating business segments

7.10.4 Product portfolio

7.10.5 Business performance

7.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 2. NEUROMONITORING DEVICES MARKET SIZE, FOR INTRACRANIAL PRESSURE MONITORING, BY REGION, 2021-2030 ($MILLION)

TABLE 3. NEUROMONITORING DEVICES MARKET FOR INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 4. NEUROMONITORING DEVICES MARKET SIZE, FOR CEREBRAL OXIMETER, BY REGION, 2021-2030 ($MILLION)

TABLE 5. NEUROMONITORING DEVICES MARKET FOR CEREBRAL OXIMETER, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 6. NEUROMONITORING DEVICES MARKET SIZE, FOR NEAR INFRARED SPECTROSCOPY, BY REGION, 2021-2030 ($MILLION)

TABLE 7. NEUROMONITORING DEVICES MARKET FOR NEAR INFRARED SPECTROSCOPY, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 8. NEUROMONITORING DEVICES MARKET SIZE, FOR SPECKLE IMAGING, BY REGION, 2021-2030 ($MILLION)

TABLE 9. NEUROMONITORING DEVICES MARKET FOR SPECKLE IMAGING, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 10. NEUROMONITORING DEVICES MARKET SIZE, FOR DOPPLER ULTRASOUND, BY REGION, 2021-2030 ($MILLION)

TABLE 11. NEUROMONITORING DEVICES MARKET FOR DOPPLER ULTRASOUND, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 12. NEUROMONITORING DEVICES MARKET SIZE, FOR EEG, BY REGION, 2021-2030 ($MILLION)

TABLE 13. NEUROMONITORING DEVICES MARKET FOR EEG, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 14. NEUROMONITORING DEVICES MARKET SIZE, FOR FETAL/NEONATAL NEURO-MONITORING DEVICES, BY REGION, 2021-2030 ($MILLION)

TABLE 15. NEUROMONITORING DEVICES MARKET FOR FETAL/NEONATAL NEURO-MONITORING DEVICES, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 16. NEUROMONITORING DEVICES MARKET SIZE, FOR MICRO ULTRASOUND, BY REGION, 2021-2030 ($MILLION)

TABLE 17. NEUROMONITORING DEVICES MARKET FOR MICRO ULTRASOUND, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 18. NEUROMONITORING DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2030 ($MILLION)

TABLE 19. NEUROMONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 20. NEUROMONITORING DEVICES MARKET, BY REGION, 2021-2030 ($MILLION)

TABLE 21. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 22. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 23. U.S. NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 24. CANADA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 25. MEXICO NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 26. EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 27. EUROPE NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 28. GERMANY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 29. UNITED KINGDOM NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 30. FRANCE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 31. SPAIN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 32. ITALY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 33. REST OF EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 34. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 35. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 36. CHINA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 37. JAPAN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 38. INDIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 39. SOUTH KOREA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 40. AUSTRALIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 41. REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 42. LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 43. LAMEA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)

TABLE 44. BRAZIL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 45. SAUDI ARABIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 46. UAE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 47. SOUTH AFRICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 48. REST OF LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)

TABLE 49.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 50.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS

TABLE 51.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 52.KONINKLIJKE PHILIPS N.V.: NET SALES,

TABLE 53.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 54.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 55.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS

TABLE 56.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 57.NIHON KOHDEN CORPORATION: NET SALES,

TABLE 58.NIHON KOHDEN CORPORATION: KEY STRATERGIES

TABLE 59.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT

TABLE 60.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS

TABLE 61.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO

TABLE 62.NATUS MEDICAL INCORPORATED: NET SALES,

TABLE 63.NATUS MEDICAL INCORPORATED: KEY STRATERGIES

TABLE 64.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 65.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 66.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 67.MEDTRONIC PLC: NET SALES,

TABLE 68.MEDTRONIC PLC: KEY STRATERGIES

TABLE 69.GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 70.GE HEALTHCARE: OPERATING SEGMENTS

TABLE 71.GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 72.GE HEALTHCARE: NET SALES,

TABLE 73.GE HEALTHCARE: KEY STRATERGIES

TABLE 74.NUVASIVE, INC.: COMPANY SNAPSHOT

TABLE 75.NUVASIVE, INC.: OPERATING SEGMENTS

TABLE 76.NUVASIVE, INC.: PRODUCT PORTFOLIO

TABLE 77.NUVASIVE, INC.: NET SALES,

TABLE 78.NUVASIVE, INC.: KEY STRATERGIES

TABLE 79.ADVANCED BRAIN MONITORING, INC.: COMPANY SNAPSHOT

TABLE 80.ADVANCED BRAIN MONITORING, INC.: OPERATING SEGMENTS

TABLE 81.ADVANCED BRAIN MONITORING, INC.: PRODUCT PORTFOLIO

TABLE 82.ADVANCED BRAIN MONITORING, INC.: NET SALES,

TABLE 83.ADVANCED BRAIN MONITORING, INC.: KEY STRATERGIES

TABLE 84.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: COMPANY SNAPSHOT

TABLE 85.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: OPERATING SEGMENTS

TABLE 86.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: PRODUCT PORTFOLIO

TABLE 87.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: NET SALES,

TABLE 88.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: KEY STRATERGIES

TABLE 89.RIMED LTD.: COMPANY SNAPSHOT

TABLE 90.RIMED LTD.: OPERATING SEGMENTS

TABLE 91.RIMED LTD.: PRODUCT PORTFOLIO

TABLE 92.RIMED LTD.: NET SALES,

TABLE 93.RIMED LTD.: KEY STRATERGIES

TABLE 94.SPECIALTYCARE: COMPANY SNAPSHOT

TABLE 95.SPECIALTYCARE: OPERATING SEGMENTS

TABLE 96.SPECIALTYCARE: PRODUCT PORTFOLIO

TABLE 97.SPECIALTYCARE: NET SALES,

TABLE 98.SPECIALTYCARE: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.NEUROMONITORING DEVICES MARKET SEGMENTATION

FIGURE 2.NEUROMONITORING DEVICES MARKET,2021-2030

FIGURE 3.NEUROMONITORING DEVICES MARKET,2021-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.NEUROMONITORING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.REGULATORY GUIDELINES

FIGURE 13.VALUE CHAIN ANALYSIS

FIGURE 14.MARKET SHARE ANALYSIS

FIGURE 15.KEY REGULATION ANALYSIS

FIGURE 16.PATENT ANALYSIS BY COMPANY

FIGURE 17.PATENT ANALYSIS BY COUNTRY

FIGURE 18.NEUROMONITORING DEVICES MARKET,BY PRODUCT,2021(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INTRACRANIAL PRESSURE MONITORING NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CEREBRAL OXIMETER NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF NEAR INFRARED SPECTROSCOPY NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SPECKLE IMAGING NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DOPPLER ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF EEG NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF FETAL/NEONATAL NEURO-MONITORING DEVICES NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF MICRO ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS NEUROMONITORING DEVICES MARKET,2021-2030(%)

FIGURE 28.NEUROMONITORING DEVICES MARKET BY REGION,2021

FIGURE 29.U.S. NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 30.CANADA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 31.MEXICO NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 32.GERMANY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 33.UNITED KINGDOM NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 34.FRANCE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 35.SPAIN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 36.ITALY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 37.REST OF EUROPE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 38.CHINA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 39.JAPAN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 40.INDIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 41.SOUTH KOREA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 42.AUSTRALIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 43.REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 44.BRAZIL NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 45.SAUDI ARABIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 46.UAE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 47.SOUTH AFRICA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 48.REST OF LAMEA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)

FIGURE 49. TOP WINNING STRATEGIES, BY YEAR

FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 53.COMPETITIVE DASHBOARD

FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)

FIGURE 56.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)

FIGURE 57.NATUS MEDICAL INCORPORATED.: NET SALES ,($MILLION)

FIGURE 58.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 59.GE HEALTHCARE.: NET SALES ,($MILLION)

FIGURE 60.NUVASIVE, INC..: NET SALES ,($MILLION)

FIGURE 61.ADVANCED BRAIN MONITORING, INC..: NET SALES ,($MILLION)

FIGURE 62.INTRANERVE NEUROSCIENCE HOLDINGS, LLC.: NET SALES ,($MILLION)

FIGURE 63.RIMED LTD..: NET SALES ,($MILLION)

FIGURE 64.SPECIALTYCARE.: NET SALES ,($MILLION